See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411685_2024_Vistagen_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001411685, Vistagen Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 17,507,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 507,000 |
| 3 | remainder_Assets | 3,075,000 |
| 4 | LiabilitiesCurrent | 4,574,000 |
| 5 | LiabilitiesNoncurrent | 4,435,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,766,105 |
| 9 | ResearchAndDevelopmentExpense | 47,656,397 |
| 10 | remainder_Expenses | 1,293,487 |
| 11 | remainder_Revenues | 296,819 |
| 12 | remainder_NetIncome | 24,626 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,089,000 |
| 1 | Liabilities | 9,009,000 |
| 2 | Expenses | 63,715,989 |
| 3 | Revenues | 296,819 |
| 4 | StockholdersEquity | 12,080,000 |
| 5 | NetIncome | -63,394,544 |
| 6 | ComprehensiveNetIncome | -63,394,544 |
| 7 | BaseVar | 47,067,717 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.46 |
| 9 | EconomicCapitalRatio | 0.868 |
Edgar->Model Mapping
Feature Distribution
Change over Time
